Ticehurst Rob, Thomast Mark
Auckland City Hospital, Auckland, New Zealand.
N Z Med J. 2011 Apr 15;124(1332):9-20.
We aimed to determine the level of antimicrobial consumption by adult inpatients at Auckland City Hospital (Auckland, New Zealand) and to compare our findings with those in other developed nations.
We used the computerised records of the central Auckland District Health Board (ADHB) pharmacy to measure the amount of antimicrobials dispensed to inpatients (excluding psychiatric units, day stay units and outpatient clinics) during 2006 to 2009. The total weight of each antimicrobial dispensed was used to determine the number of defined daily doses (DDDs) dispensed. The Information Management and Technical Services department of ADHB provided data on the number of admissions and inpatient days, and these data, together with information from the 2006 census, were used to calculate antimicrobial consumption for adult inpatients measured in DDDs/100 admissions, DDDs/100 inpatient days and DDDs/1000 population.
Total antimicrobial consumption by adult inpatients increased from 74 DDDs/100 inpatient days in 2006 to 80.3 DDDs/100 inpatient days in 2009. The level of consumption did not vary greatly with the season. The total level of consumption was very similar to that seen in adult inpatients in hospitals in Australia and Scandinavian countries. The level of consumption of fluoroquinolones, third or fourth generation cephalosporins, carbapenems and vancomycin (antimicrobial classes that are not available for unrestricted use in Auckland City Hospital) was comparable to or less than that seen in adult inpatients in hospitals in Australia or Scandinavian countries. Beta-lactamase susceptible penicillins (such as benzyl penicillin and phenoxymethylpenicillin) comprised a relatively small proportion of total penicillin use and beta-lactamase inhibitor combinations (predominantly amoxicillin/clavulanate) a relatively large proportion of total penicillin use, when compared with Scandinavian hospitals.
The antimicrobial stewardship programme at Auckland City Hospital has resulted in a generally prudent level of consumption in recent years. Opportunities exist to improve the pattern of antimicrobial prescribing in the expectation that this will help to slow the spread of antimicrobial resistance in our community.
我们旨在确定奥克兰市医院(新西兰奥克兰)成年住院患者的抗菌药物使用水平,并将我们的研究结果与其他发达国家的进行比较。
我们利用奥克兰中区卫生局(ADHB)药房的计算机记录,来测量2006年至2009年期间发放给住院患者(不包括精神科病房、日间病房和门诊诊所)的抗菌药物数量。每种发放的抗菌药物的总重量用于确定发放的限定日剂量(DDD)数量。ADHB的信息管理和技术服务部门提供了入院人数和住院天数的数据,这些数据与2006年人口普查信息一起,用于计算以DDD/100次入院、DDD/100住院日和DDD/1000人口衡量的成年住院患者的抗菌药物使用量。
成年住院患者的抗菌药物总使用量从2006年的74 DDD/100住院日增加到2009年的80.3 DDD/100住院日。使用水平随季节变化不大。总使用水平与澳大利亚和斯堪的纳维亚国家医院成年住院患者的情况非常相似。氟喹诺酮类、第三代或第四代头孢菌素、碳青霉烯类和万古霉素(在奥克兰市医院不能无限制使用的抗菌药物类别)的使用水平与澳大利亚或斯堪的纳维亚国家医院成年住院患者的相当或更低。与斯堪的纳维亚医院相比,β-内酰胺酶敏感青霉素(如苄青霉素和苯氧甲基青霉素)在青霉素总使用量中所占比例相对较小,而β-内酰胺酶抑制剂组合(主要是阿莫西林/克拉维酸)在青霉素总使用量中所占比例相对较大。
近年来,奥克兰市医院的抗菌药物管理计划使抗菌药物使用水平总体较为合理。仍有机会改善抗菌药物的处方模式,期望这将有助于减缓我们社区中抗菌药物耐药性的传播。